Pharmacokinetics, Safety and Tolerability of Bencycloquidium Bromide, a Novel Selective Muscarinic M1/M3 Receptor Antagonist, After Single and Multiple Intranasal Doses in Healthy Chinese Subjects: An Open-Label, Single-Center, First-in-Human Study

Author： Sun Luning  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.12, Iss.1, 2012-03, pp. : 17-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Tolerability of Single and Multiple Doses of Ticagrelor in Healthy Chinese Subjects: An Open-Label, Sequential, Two-Cohort, Single-Centre Study

By Li Haiyan  

Clinical Drug Investigation, Vol. 32, Iss. 2, 2012-02 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Safety, and Tolerability Following Single and Multiple Doses of Pibrentasvir in a First‐in‐Human Study

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 44-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Orally Administered Single- and Multiple-Dose Olopatadine in Healthy Chinese Subjects: An Open-Label Study

By Chu Nan-Nan   Chen Wei-Li   Xu Hong-Rong   Li Xue-Ning  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 451-457

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Aliskiren in Healthy Chinese Subjects: A Randomized, Single-Blind, Parallel-Group, Placebo-Controlled Study

By Hu Pei  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 221-228

Adis International

Access to resources Recommend Favorite

Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects: A Single-Sequence, Open-Label Study

By Harrison Brooke  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 875-885

Adis International

Access to resources Recommend Favorite